In vivo models of hypercalcemia of malignancy.
Schilling
T
T
Department of Internal Medicine I-Endocrinology and Metabolism, University of Heidelberg, Germany.
D000818:Animals; D006224:Cricetinae; D004195:Disease Models, Animal; D004285:Dogs; D006133:Growth Substances / Q000502:physiology; D006801:Humans; D006934:Hypercalcemia / Q000209:etiology / Q000503:physiopathology* / Q000628:therapy; D051379:Mice; D009363:Neoplasm Proteins / Q000502:physiology; D009374:Neoplasms, Experimental / Q000150:complications*; D010257:Paraneoplastic Syndromes / Q000209:etiology / Q000503:physiopathology* / Q000628:therapy; D044162:Parathyroid Hormone-Related Protein; D011506:Proteins / Q000502:physiology; D011817:Rabbits; D051381:Rats
D006133:Growth Substances; D009363:Neoplasm Proteins; C470121:PTHLH protein, human; D044162:Parathyroid Hormone-Related Protein; D011506:Proteins